Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Protracted administration of diazepam elicits tolerance, whereas discontinuation of treatment results in signs of dependence. Tolerance to the anticonvulsant action of diazepam is present in an early phase (6, 24, and 36 h) but disappears in a late phase (72–96 h) of withdrawal. In contrast, signs of dependence such as decrease in open-arm entries on an elevated plus-maze and increased susceptibility to pentylenetetrazol-induced seizures were apparent 96 h (but not 12, 24, or 48 h) after diazepam withdrawal. During the first 72 h of withdrawal, tolerance is associated with changes in the expression of GABA A (γ-aminobutyric acid type A) receptor subunits (decrease in γ 2 and α 1 ; increase in α 5 ) and with an increase of mRNA expression of the most abundant form of glutamic acid decarboxylase (GAD), GAD 67 . In contrast, dl -α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor GluR1 subunit mRNA and cognate protein, which are normal during the early phase of diazepam withdrawal, increase by approximately 30% in cortex and hippocampus in association with the appearance of signs of dependence 96 h after diazepam withdrawal. Immunohistochemical studies of GluR1 subunit expression with gold-immunolabeling technique reveal that the increase of GluR1 subunit protein is localized to layer V pyramidal neurons and their apical dendrites in the cortex, and to pyramidal neurons and in their dendritic fields in hippocampus. The results suggest an involvement of GABA-mediated processes in the development and maintenance of tolerance to diazepam, whereas excitatory amino acid-related processes (presumably via AMPA receptors) may be involved in the expression of signs of dependence after withdrawal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, glutamate receptor mRNA and protein changes may be dynamic during withdrawal, with unchanged levels during the early phase of withdrawal but changes occurring several days later [112].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [112]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macdonald, R. L., & Olsen, R. W. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003033 · Cited by 1,975
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Molecular and neuronal substrate for the selective attenuation of anxiety
Löw, K., Crestani, F., Keist, R., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Rülicke, T., Bluethmann, H., Möhler, H., et al. (2000) · Science · doi:10.1126/science.290.5489.131 · Cited by 946
McKernan, R. M., Rosahl, T. W., Reynolds, D. S., Sur, C., Wafford, K. A., Atack, J. R., Farrar, S., Myers, J., Cook, G., Ferris, P., et al. (2000) · Nature Neuroscience · doi:10.1038/75761 · Cited by 944
Two isoforms of glutamate decarboxylase: why?
Soghomonian, J.-J., & Martin, D. L. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(98)01270-x · Cited by 642
Benzodiazepines: use, abuse, and consequences.
Woods, J. H., Katz, J. L., & Winger, G. (1992) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00468-5 · Cited by 560
Loss of Postsynaptic GABAAReceptor Clustering in Gephyrin-Deficient Mice
Kneussel, M., Brandstätter, J. H., Laube, B., Stahl, S., Müller, U., & Betz, H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09289.1999 · Cited by 446
Local protein synthesis and its role in synapse-specific plasticity
Martin, K. C., Barad, M., & Kandel, E. R. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00128-8 · Cited by 258
Wang, H., & Olsen, R. W. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750644.x · Cited by 153
FROM GABAA RECEPTOR DIVERSITY EMERGES A UNIFIED VISION OF GABAergic INHIBITION
Costa, E. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.321 · Cited by 145
Self-citationSteward, O., & Reeves, T. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-01-00176.1988 · Cited by 143
Benzodiazepines on trial: a research strategy for their rehabilitation
Costa, E., & Guidetti, A. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10015-8 · Cited by 141
Self-citationImpagnatiello, F., Pesold, C., Longone, P., Caruncho, H., Fritschy, J. M., Costa, E., & Guidotti, A. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09071-6 · Cited by 124
Self-citationEffects of continuous diazepam administration on GABAA subunit mRNA in rat brain
Heninger, C., Saito, N., Tallman, J. F., Garrett, K. M., Vitek, M. P., Duman, R. S., & Gallager, D. W. (1990) · Journal of Molecular Neuroscience · doi:10.1007/bf02876917 · Cited by 118
Decreased GABAAreceptor subunit mRNA concentrations following chronic lorazepam administration
Kang, I., & Miller, L. G. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb09781.x · Cited by 117
Diazepam dependence prevented by glutamate antagonists.
Steppuhn, K. G., & Turski, L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6889 · Cited by 101
Experimental induction of benzodiazepine tolerance and physical dependence.
Ryan, G. P., & Boisse, N. R. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21369-6 · Cited by 88
Turrigiano, G. G. (2000) · Neuron · doi:10.1016/s0896-6273(00)81131-9 · Cited by 87
Primus, R. J., & Gallager, D. W. (1992) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(92)90078-a · Cited by 87
Tolerance to diazepam and changes in GABAA receptor subunit expression in rat neocortical areas
Pesold, C., Caruncho, H. J., Impagnatiello, F., Berg, M. J., Fritschy, J., Guidotti, A., & Costa, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00609-4 · Cited by 77
Self-citationZhao, T. J., Chiu, T. H., & Rosenberg, H. C. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10150-8 · Cited by 72
Differences between the tolerance characteristics of two anticonvulsant benzodiazepines
Gent, J. P., Feely, M. P., & Haigh, J. R. M. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90520-x · Cited by 66
Primus, R. J., Yu, J., Xu, J., Hartnett, C., Meyyappan, M., Kostas, C., Ramabhadran, T. V., & Gallager, D. W. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12410-5 · Cited by 60
Tietz, E. I., Huang, X., Weng, X., Rosenberg, H. C., & Chiu, T. H. (1993) · Journal of Molecular Neuroscience · doi:10.1007/bf02821559 · Cited by 57
Auta, J., Romeo, E., Kozikowski, A. P., Ma, D., Costa, E., & Guidotti, A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38161-9 · Cited by 57
Self-citationAuta, J., Giusti, P., Guidotti, A., & Costa, E. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22535-6 · Cited by 49
Self-citationLongone, P., Impagnatiello, F., Guidotti, A., & Costa, E. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00071-8 · Cited by 48
Self-citationKlein, R. L., & Harris, R. A. (1996) · Japanese Journal of Pharmacology · doi:10.1254/jjp.70.1 · Cited by 41
The NMDA Receptor Competitive Antagonist CPP Modulates Benzodiazepine Tolerance and Discontinuation
Koff, J. M., Pritchard, G. A., Greenblatt, D. J., & Miller, L. G. (2008) · Pharmacology · doi:10.1159/000139531 · Cited by 33
Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change.
Gallager, D. W., & Primus, R. J. (1993) · PubMed · Cited by 28
Pharmacological mechanisms of benzodiazepine withdrawal
Nutt, D. J. (1990) · Journal of Psychiatric Research · doi:10.1016/0022-3956(90)90041-n · Cited by 27
Longone, P., Impagnatiello, F., Mienville, J., Costa, E., & Guidotti, A. (1998) · Journal of Molecular Neuroscience · doi:10.1385/jmn:11:1:23 · Cited by 25
Self-citationDunworth, S. J., & Stephens, D. N. (1998) · Psychopharmacology · doi:10.1007/s002130050571 · Cited by 23
Research works printed but not linked: 11
- Woods J H, Katz L A, Winger G. Pharmacol Rev. 1992;44:151–347. [PubMed] [Google Scholar]
- Costa E, Auta J, Guidotti A. In: Handbook of Experimental Pharmacology: Pharmacology of Inhibitory Amino Acid Transmitters. Möhler H, editor. Vol. 150. Berlin: Springer; 2000. pp. 227–250. [Google Scholar]
- Ryan G P, Boisse N R. J Pharmacol Exp Ther. 1983;226:100–107. [PubMed] [Google Scholar]
- Impagnatiello F, Pesold C, Longone P, Caruncho H, Fritschy J M, Costa E, Guidotti A. Mol Pharmacol. 1996;49:822–831. [PubMed] [Google Scholar]
- Zhao T J, Chiu T H, Rosenberg H C. Mol Pharmacol. 1994;45:657–663. [PubMed] [Google Scholar]
- Primus R J, Yu J, Xu J, Hartnett C, Meyyappan M, Kostas C, Ramabhadran T V, Gallager D W. J Pharmacol Exp Ther. 1996;276:882–890. [PubMed] [Google Scholar]
- Gallager D W, Primus R J. Biochem Soc Symp. 1993;59:135–151. [PubMed] [Google Scholar]
- Auta J, Romeo E, Kozikowski A, Ma D, Costa E, Guidotti A. J Pharmacol Exp Ther. 1993;265:649–656. [PubMed] [Google Scholar]
- Auta J, Giusti P, Guidotti A, Costa E. J Pharmacol Exp Ther. 1994;270:1262–1269. [PubMed] [Google Scholar]
- Grayson D R, Ikonomovic S. Neuromethods. 1998;34:127–151. [Google Scholar]
- Eberwine J H. In: Dendrites. Stuart G, Spruston N, Hausser M, editors. New York: Oxford Univ. Press; 1999. pp. 35–67. [Google Scholar]
Cited by
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Fatemi, S. H., Halt, A. R., Stary, J. M., Kanodia, R., Schulz, S. C., & Realmuto, G. R. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01430-0 · Cited by 500
GABAergic dysfunction in schizophrenia: new treatment strategies on the horizon
Guidotti, A., Auta, J., Davis, J. M., Dong, E., Grayson, D. R., Veldic, M., Zhang, X., & Costa, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2212-8 · Cited by 262
“Also, the expression of AMPA-preferring glutamatergic receptor subunits in dendritic spine postsynaptic densities of the pyramidal neurons of different cortical areas may be upregulated and thus may complicate matters (Izzo et al. 2001).”
BackgroundSelf-citationLiu, W. S., Pesold, C., Rodriguez, M. A., Carboni, G., Auta, J., Lacor, P., Larson, J., Condie, B. G., Guidotti, A., & Costa, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051614698 · Cited by 226
Self-citationRegulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Metadata
- Authors
- Izzo, E., Auta, J., Impagnatiello, F., Pesold, C., Guidotti, A., & Costa, E.
- Affiliations
- University of Illinois Chicago (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-03-13
- Volume
- 98
- Issue
- 6
- Pages
- 3483-3488
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC30679
- OpenAlex
- W2068003831
- Cited by
- 90
- References
- 33
- Citations by year
- 2026: 5 · 2025: 3 · 2023: 3 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 3
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of California, Los Angeles
- National Institute of Mental Health (MH 49486, MH-56500, R01MH056500, R01MH049486)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- benzodiazepine dependence, diazepam withdrawal, glutamic acid decarboxylase, GAD67, GABAA receptor subunits, glutamate receptors, excitatory amino acids, pentylenetetrazole-induced seizures, elevated plus maze, pyramidal neurons, hippocampus, cerebral cortex
- MeSH terms
- Animals, Brain, Diazepam, Drug Tolerance, Frontal Lobe, Glutamate Decarboxylase, Hippocampus, Isoenzymes, Male, Occipital Lobe, Rats, Inbred F344, RNA, Messenger, Time Factors, Receptors, AMPA, GABA Modulators, Substance-Related Disorders, Gene Expression Profiling, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.